One of the current battlegrounds in cases involving large-scale fraud on the government is whether and when the government or relators may use statistical sampling to prove liability or damages. The government and relators often argue that without the ability to extrapolate results from a smaller representative sample of claims – for example, claims for reimbursement for diagnostic tests to Medicare or Medicaid – the largest frauds will go unpunished because it is impractical to try a case involving thousands of individual treatment decisions. On the other side, defendants typically object that statistical sampling and extrapolation methods deprive them of the ability to offer a defense as to each alleged false claim on an individualized basis. The resolution of this issue has dramatic consequences for many of the largest False Claims Acts cases and investigations.
Join Jeanne A. Markey, Partner and Co-Chair of the False Claims Act/Whistleblower Practice Group at Cohen Milstein Sellers & Toll, and Raymond M.
Excellent use of jelly beans to illustrate the point. This sort of demonstration is rare in CLE.
Recommended to a colleague during the call.
Excellent CLE. Very informative and the information was presented in a clear and concise manner. Thank you
Good sampling of relevant materials and basic primer on the topic
Very able presenters.